Searched for
WOCKHARDT SHARES FALL
Behind India's Rs 5.5 lakh crore FII selloff lies a hidden list of 84 multibagger winnersForeign institutional investors have sold Indian stocks worth Rs 5.5 lakh crore. However, a hidden list reveals 84 stocks where FIIs have a...- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
- Ahead of Market: 10 things that will decide stock market action on TuesdayBenchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent ...
- Wockhardt among 8 stocks hit 52-week highs, rally up to 55% in a monthDespite a 508-point fall in the Sensex on Monday, eight BSE 500 stocks climbed to fresh 52-week highs, signaling strong investor confidence...
- Ahead of Market: 10 things that will decide stock market action on MondayIndian equity markets ended sharply lower on May 29 amid broad-based selling, MSCI-driven flows and rising volatility. Technical indicators...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian benchmark indices ended slightly lower amid weakness in FMCG, IT and banking stocks, while analysts highlighted improving technical ...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weaknessSmallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...
- Wockhardt shares bounce back 4% after two-day slumpWockhardt shares on December 1 jumped 19% after the US FDA accepted the company’s New Drug Application for Zaynich, its first-in-class anti...
- Wockhardt shares down nearly 4% as Q1 net profit divesThe scrip went down 3.64 per cent to end at Rs 781.15 on BSE. During the day, it shed 5.44 per cent to Rs 766.50.
- Neutral Wockhardt Ltd., target Rs 1015.0 : Macquarie Capital SecuritiesMacquarie says expects stock to trade at discount to fair value of Rs 1,320 in the medium term as regulatory uncertainty prevails
- Wockhardt slips 11% on USFDA concerns, down 29% in 4 sessionsThe stock fell 11.02 per cent to hit a low of Rs 1,146.40.
- Wockhardt Q4 net plunges 54% to Rs 34 croreDrug firm Wockhardt today reported 54.22 per cent decline in consolidated net profit at Rs 34.08 crore for the fourth quarter ended March 3...
- Wockhardt extends overnight losses post import alertShares of Wockhardt extended losses for second consecutive session as sentiment turned bearish in the counter after the USFDA issued import...
- Wockhardt revenues may dip up to $250 m on USFDA banWockhardt may suffer an annual revenue fall of up to $250 million and its American operations may grind to a halt.
- Wockhardt continues to slide as street loses faithOn July 18, the US FDA said in a warning letter that the company “repeatedly delayed, denied, limited an inspection or refused to permit th...
- Wockhardt crash won't affect mutual fund equity schemesThe crash in the share price of drug maker Wockhardt over the past two trading sessions may have sent jitters across the investing community
- Wockhardt allays investor fears on US 'import ban'USFDA had imposed a ban on imports from Wockhardt's Aurangabad factory in Maharashtra, citing quality concerns of drugs.
- Wockhardt in talks with PE firms to raise $200 mnWockhardt is in talks with private equity firms to raise $150-200 million to meet convertible bond redemptions that fall due in October, so...
Load More
